Taken together, our results demonstrated that marine n-3 PUFAs from fish oils lower the risk of T2D development in people with prediabetes and interacted with variants at GLUT4, which may owe to the improvement of glucose homeostasis in skeletal muscle. The gene discussed is SLC2A4; the disease is type 2 diabetes mellitus.